Company profile

ASIT biotech SA specializes in the research and development of immunotherapeutic products for allergy treatment.

Source: Cofisem - Last Update: 10 Jul 2020
Key Executives
Chief Executive Officer Michel Baijot
Chief Financial Officer Frank Hazevoets
Human Resources Director Marie-Pierre Beaumont
Source: Cofisem - Last Update: 04 Feb 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 4
Income from ordinary activities 4
Operating income -15,951 -12,767 -11,976 -12,278 -7,640
Cost (net) of financial indebtedness 6 -54 -71
Equity-accounted companies' contribution to results
Net profit from discontinued activities
Net income -15,656 -14,321 -11,986 -12,339 -7,715
Net income (Group share) -15,656 -14,321 -11,986 -12,339 -7,715
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 10 Jul 2020
Shareholder information
Flottant 61.00 %
Rodolphe Spoelberch 8.60 %
SFPI 6.50 %
Noshaq 4.90 %
SRIW SA 4.50 %
Epimède 4.40 %
Société Régionale d'Investissements de Bruxelles 4.20 %
3T Finance 3.20 %
Chagral Invest 2.50 %
Managers and Directors 0.20 %
Source: Cofisem - Last Update: 23 Jun 2020

Financial analysis

Equity research report, in partnership with Morningstar

View Report

Address

ASIT biotech SA

Rue des Chasseurs Ardennais 7
BE-4031 Liège
Belgium
Phone number: +32 2 264 03 90
Source: Cofisem - Last Update: 10 Jul 2020

Contact

Hans Herklots
Phone number: +41 79 598 7149
Source: ASIT biotech SA - Last Update: 10 Jul 2020